NOVAVAX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.09 USD | +3.54% |
|
+3.02% | -14.79% |
| 15/04 | Sector Update: Health Care Stocks Gain Monday Afternoon | MT |
| 15/04 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |  |
Chart calendar Novavax, Inc.
f46ec689578.ajexZM9E_aSEzzvWGxLRS4wSadd6P5AOK9RyujOmPWU.U2DDV_4GzZDPiF2GTXOjCaF8Xp4laMpbHbMB4HSWdl0vYpwupi6sl-qtbg~b00520670a5152783e326032fe3a18d2
Upcoming events on Novavax, Inc.
Past events on Novavax, Inc.
| 04/04/2024 12:10 am | World Vaccine Congress |
| 03/04/2024 07:55 pm | World Vaccine Congress |
| 03/04/2024 07:40 pm | World Vaccine Congress |
| 07/03/2024 12:00 am | TD Cowen Health Care Conference |
| 28/02/2024 07:00 pm | Q4 2023 Earnings Call |
| 28/02/2024 06:30 pm | Q4 2023 Earnings Release |
| 09/01/2024 06:45 am | JPMorgan Healthcare Conference |
| 15/11/2023 02:30 pm | Jefferies London Healthcare Conference |
| 09/11/2023 07:02 pm | Q3 2023 Earnings Release |
| 09/11/2023 07:00 pm | Q3 2023 Earnings Call |
| 19/10/2023 02:00 pm | World Vaccine Congress - Perretti, A |
| 18/10/2023 05:30 pm | World Vaccine Congress - Shinde, V |
| 17/10/2023 05:15 pm | World Vaccine Congress - Zatonski, M |
| 14/10/2023 09:45 pm | IDWeek Conference - Poster No. - 2337 |
| 13/10/2023 09:45 pm | IDWeek Conference - Poster No. - 1371 |
| 12/09/2023 07:45 pm | Baird Global Healthcare Conference |
| 12/09/2023 02:00 am | H.C. Wainwright Global Investment Conference |
| 08/08/2023 06:00 pm | Q2 2023 Earnings Call |
| 08/08/2023 05:30 pm | Q2 2023 Earnings Release |
| 11/07/2023 06:00 pm | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 18,7 11,8 57.99% | 476 398 19.36% | 1 146 1 263 -9.25% | 1 982 1 947 1.77% | 984 1 014 -3.03% | 846 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -616 -455 -35.42% | -525 -487 -7.88% | -111 |
|
EBIT Million USD | Released Forecast Spread | -130 -121 -7.5% | -417 -393 -6.04% | -1 687 -979 -72.21% | -645 -480 -34.41% | -567 -424 -33.66% | -92,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -133 -128 -3.94% | -418 -383 -9.33% | -1 715 -1 007 -70.2% | -654 -548 -19.24% | -543 -394 -37.66% | -125 |
|
Net income Million USD | Released Forecast Spread | -133 -130 -2.38% | -418 -383 -9.33% | -1 744 -1 021 -70.82% | -658 -548 -20.13% | -545 -413 -31.9% | -112 |
|
EPS USD | Released Forecast Spread | -5,51 -5,42 -1.59% | -7,27 -6,58 -10.53% | -23,4 -13,7 -71.07% | -8,42 -6,98 -20.66% | -5,41 -4,22 -28.15% | -0,72 |
| Announcement Date | 11/03/20 | 01/03/21 | 28/02/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 222 332 -33.03% | 704 845 -16.71% | 186 1 017 -81.72% | 735 555 32.24% | 357 383 -6.72% | 81,0 94,5 -14.35% | 424 259 63.88% | 187 96,5 93.76% | 291 322 -9.51% | 101 | 76,7 | 77,4 | 617 |
|
EBITDA Million USD | Released Forecast Spread | -119 310 -138.36% | -173 -120 -43.73% | -149 | -121 | -109 | 186 | |||||||
|
EBIT Million USD | Released Forecast Spread | -825 -114 -626.51% | 209 247 -15.35% | -483 486 -199.33% | -127 139 -191.53% | -244 -90,2 -170.23% | -313 -278 -12.54% | 55,5 -121 145.98% | -126 -223 43.74% | -184 -40,9 -348.58% | -137 | -113 | -112 | 260 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -830 -118 -604.95% | 206 242 -14.95% | -509 495 -202.89% | -166 93,2 -278.36% | -185 -87,8 -110.23% | -293 -299 2.07% | 57,9 -94,1 161.53% | -131 -214 38.43% | -177 -26,9 -555.91% | -141 | -116 | -113 | 244 |
|
Net income Million USD | Released Forecast Spread | -846 -124 -584.19% | 203 213 -4.69% | -510 449 -213.66% | -169 132 -227.32% | -182 -74,2 -145.57% | -294 -291 -1.16% | 58,0 -101 157.16% | -131 -217 39.77% | -178 -46,5 -283.41% | -139 | -114 | -111 | 239 |
|
EPS USD | Released Forecast Spread | -11,2 -1,80 -520.36% | 2,56 2,65 -3.54% | -6,53 5,50 -218.68% | -2,15 1,64 -231.02% | -2,28 -1,01 -126.76% | -3,41 -3,42 0.29% | 0,58 -1,16 149.81% | -1,26 -2,29 45.05% | -1,44 -0,45 -221.19% | -1,06 | -0,85 | -0,77 | 1,66 |
| Announcement Date | 28/02/22 | 09/05/22 | 08/08/22 | 08/11/22 | 28/02/23 | 09/05/23 | 08/08/23 | 09/11/23 | 28/02/24 | - | - | - | - |
More events
Past sector events for Novavax, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NVAX Stock
- Calendar Novavax, Inc.
